1. Birth Outcomes Among People with Hepatitis C in Pregnancy — Three U.S. States, 2018–2021.
- Author
-
Woodworth, Kate R., Newton, Suzanne M., Tannis, Ayzsa, Reynolds, Megan R., Olsen, Emily O., Sizemore, Lindsey, Wingate, Heather, Orkis, Lauren, Reynolds, Bethany, Longcore, Nicole, Thomas, Nadia, Kim, Shin Y., Panagiotakopoulos, Lakshmi, Wester, Carolyn, Delman, Dana Meaney, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
HEPATITIS C diagnosis ,SUBSTANCE abuse ,PUBLIC health surveillance ,SMALL for gestational age ,NEONATAL abstinence syndrome ,RESEARCH funding ,PREMATURE infants ,PREGNANCY outcomes ,PREGNANT women ,ATTITUDES of mothers ,NEONATAL intensive care ,DESCRIPTIVE statistics ,PREGNANCY complications ,HEPATITIS C ,DATA analysis software ,CONFIDENCE intervals ,DISEASE risk factors ,DISEASE complications ,PREGNANCY - Abstract
Introduction: There are limited and conflicting data regarding the impact of hepatitis C in pregnancy on adverse birth outcomes. Methods: Using the Surveillance for Emerging Threats to Pregnant People and Infants Network (SET-NET), a large surveillance cohort, we describe birth outcomes among a cohort of people with HCV in pregnancy in total and by reported substance use. Results: Among 1418 infants, 89% were born to people with reported substance use during pregnancy. The proportion born preterm was 20%, 13% were small-for-gestational age and 34% of term infants required intensive care. Conclusions: Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. Significance: Incidence of hepatitis C in pregnancy is increasing. Prematurity, small-for-gestational age, and intensive care unit admission were common among this surveillance cohort of infants born to people with hepatitis C in pregnancy with high frequency of substance use. Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF